Información del producto
FKBP12 PROTAC RC32 is an innovative anticancer drug that works by inhibiting kinase activity in cancer cells. It is a potent inhibitor of the cell cycle, inducing apoptosis and halting tumor growth. FKBP12 PROTAC RC32 has been shown to be effective in human cancer cell lines, with analogs found in urine samples of patients undergoing chemotherapy. This medicinal compound targets specific kinases involved in cancer development and progression, making it a promising option for targeted therapy. Its unique protein degradation mechanism allows for selective elimination of target proteins, reducing off-target effects commonly seen with traditional inhibitors. Overall, FKBP12 PROTAC RC32 shows great potential as a powerful tool in the fight against cancer.
Propiedades químicas
Consulta técnica sobre: 3D-AVD55566 Fkbp12 protac rc32
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
